ࡱ> po  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnqRoot Entry F݂]' ov)WorkbookETExtDataSummaryInformation(  VY+j .A  .A  A. Oh+'0H T8\pF?e^ Ba= =Rq/8X@"1l[SO1l[SO1l[SO1l[SO1l[SO1l[SO1l[SO1l[SO1 l[SO1<l[SO1l[SO1l[SO1l[SO1 l[SO1?l[SO1l[SO1.lTimes New Roman1.lTimes New Roman1le[SO1Tahoma1 Tahoma1h8[SO1,8Tahoma18Tahoma18Tahoma1Tahoma1[SO1 [SO1Tahoma1Tahoma14Tahoma1 Tahoma1Tahoma1 Tahoma14Tahoma1<Tahoma1?Tahoma1>Tahoma1[SO1[SO1[SO1[SO1[SO1?[SO1?[SO1 [SO""#,##0;""\-#,##0""#,##0;[Red]""\-#,##0""#,##0.00;""\-#,##0.00#""#,##0.00;[Red]""\-#,##0.007*2_ ""* #,##0_ ;_ ""* \-#,##0_ ;_ ""* "-"_ ;_ @_ .))_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ ?,:_ ""* #,##0.00_ ;_ ""* \-#,##0.00_ ;_ ""* "-"??_ ;_ @_ 6+1_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ \$#,##0_);\(\$#,##0\)\$#,##0_);[Red]\(\$#,##0\) \$#,##0.00_);\(\$#,##0.00\)% \$#,##0.00_);[Red]\(\$#,##0.00\) 0.0_  0.00_  yyyy"."m"."d"Yes";"Yes";"No""True";"True";"False""On";"On";"Off"],[$ -2]\ #,##0.00_);[Red]\([$ -2]\ #,##0.00\)0_);[Red]\(0\)0.0_);[Red]\(0.0\)0.00_);[Red]\(0.00\)                 - * .  / ,   . , 3    $ 1 4    P P    -    * a> , *    ff7 ! " #` + ) $+ % & / @ @ ' >  9 $ 1 5     (x@ @  (x@ @  )x@ @  )|@ @  )x@ @  x@ @ x@ @ @ ` d p *x *x *| P +x@ @  (x@ @ / (1|@ @ / (x@ @ / (x@ @  (x@ @  (x@ @  (x@ @  (x@ @  *x@ @  )x / )x/ |/ |/ )|/ |/ )x@ @ / )|@ @ / )|@ @ / ,x@ @ / )x@ @  )|@ @  )|@ @  |@ @  |@ @  )|@ @  )|@ @  )x@ @ * |@ @ * |@ @ * )|@ @ * )|@ @ * )|@ @ * +x@ @ * +|@ @ * x@ @ * -x@ @ *  x@ @ * .x@ @ * p@ @  )x@@  )x@@ / )x@@  |@@ * x@@ * |@@ `@ @ 8@ @ 0@ @ (x@ @ . (x@ @ . x@ @ . )x@ @ . x. |. )x@ @ . )x@@ . x@ @ . |@ @ . x @ . 1|.  x. x @ . t. )|@ @ . x @ p  p  x@ @ . p@ @ . ||Ҟؓ}<} 00_)ef\([$}<} 00_)ef\([$}<} 00_)ef\([$}<} 00_)ef\([$}<} 00_)ef\([$}<} 00_)ef \([$}<} 00_)L\([$}<} 00_)L\([$}<} 00_)L\([$}<} 00_)L\([$}<} 00_)L\([$}<} 00_)L \([$}<} 00_)23\([$}<} 00_)23\([$}<} 00_)23\([$}<} 00_)23\([$}<}  00_)23\([$}<}! 00_)23 \([$}-}# 00_)}<}$ 00_)\([$}<}% 00_)?\([$}<}& 00_)23\([$}(}' 00_)}<}( 00_)\([$}-}) 00_)}-}+ 00_)}<}, a00_)\([$}P}- 00_)\([$#,##}}0 }00_)\([$#,##  }}1 00_)\([$???#,##??? ??? ???}(}2 00_)}(}3 00_)}<}4 }00_)\([$}<}7 e00_)\([$}}8 ???00_)\([$???#,##??? ??? ???}}9 ??v00_)̙\([$#,##  }-}; 00_)}<}< 00_)\([$}<}= 00_)\([$}<}> 00_)\([$}<}? 00_)\([$}<}@ 00_)\([$}<}A 00_) \([$}x}B00_)\([$#,##  }}D}}E}(}F 00_)}(}G 00_)}(}H 00_)}-}O 00_)}-}P 00_)}-}Q 00_)}(}S 00_)}-}Tef _)}-}Uef _)}-}Vef _)}-}Wef_)}-}Xef_)}-}YL_)}-}ZL_)}-}[L_)}A}\ L_)L[$}x}] L_)ef L[$#,##  }d}^ L_)ef L[$#,##  }x}_ef L_)L[$#,##  }x}`ef L_)L[$#,##  }}a L_)ef L[$#,##  }x}bef L_)L[$#,##  }<}c L_)ef L[$}<}d L_)ef L[$}<}e L_)ef L[$}<}f 333L_)ef L[$}<}g L_)efL[$}<}h L_)efL[$}<}i L_)efL[$}(}jefL_)}(}kefL_)}<}l L_)efL[$}<}m L_)efL[$}<}n L_)efL[$}(}oefL_)}(}pefL_)}<}q L_)efL[$}<}r L_)efL[$}<}s L_)efL[$}<}t L_)efL[$}<}u L_)efL[$}(}vefL_)}<}w (((L_)efL[$}(}xefL_)}<}y L_)efL[$}(}zL_)}(}{ L_)}<}| L_)ef L[$}<}} L_)efL[$}(}~efL_)}(}efL_)}-}ef_)}-}ef_)}(}eff_)}<} f_)efL[$}(}eff_)}(}eff_)}<} f_)efL[$}<} f_)efL[$}(}eff_)}(}eff_)}(}eff_)}(}eff_)}(}eff_)}(}eff_)}(}eff_)}<} f_)efL[$}(}f_)}(}f_)}(}f_)}(}eff_)}(}eff_) 20% - @wr 1B 20% - @wr 1 ef  20% - @wr 2B" 20% - @wr 2 ef  20% - @wr 3B& 20% - @wr 3 ef  20% - @wr 4B* 20% - @wr 4 ef  20% - @wr 5B. 20% - @wr 5 ef  20% - @wr 6B2 20% - @wr 6  ef  40% - @wr 1B 40% - @wr 1 L  40% - @wr 2B# 40% - @wr 2 L渷  40% - @wr 3B' 40% - @wr 3 L  40% - @wr 4B+ 40% - @wr 4 L  40% - @wr 5B/ 40% - @wr 5 L  40% - @wr 6B3 40% - @wr 6  Lմ  60% - @wr 1B 60% - @wr 1 23  60% - @wr 2B$ 60% - @wr 2 23ږ  60% - @wr 3B( 60% - @wr 3 23כ  60% - @wr 4B, 60% - @wr 4 23  60% - @wr 5B0 60% - @wr 5 23 ! 60% - @wr 6B4 60% - @wr 6  23 "~vRk #h+h I}% $h 18h 1 I}O %h 28h 2 I}? &h 38h 3 I}23 'h 4*h 4 I}(]0]  8^ĉ )8^ĉ 2/8^ĉ 2 % *8^ĉ 3+-c %,}Y0}Y  a -Gl;`BGl;` OO.'^/ '^[0] 0{j{  } 1hgUSCQ@wr 36%@wr 3 Y  ?@wr 46)@wr 4 d  @@wr 56-@wr 5 K  A@wr 661@wr 6  F  Blʑ^ lʑ  XTableStyleMedium9PivotStyleLight16` "ZSX UxX -NoVVa| c TMO!k Pv^RN0N\O  Re t^/g yv!h0w00V[~Ylof[botf[SCIN:Sς]'Yf[of[boBRf[1.N:Sof[_uirNuSof[1.SCI 1.ς]'Yf[of[boirRg1.ς]'Yf[of[b 2.ς]'Yf[of[b^Sf[bY Tf[SNN T R T\Oc Tq_TVP['Y{|R:S,{NUSMOoirSf[1.N:SN:Sd[^Y,{NN\OcCgN)R 1.SCI 2.SCIuof[e{|+RSCI/SCIE/8h_g R/nfg R)of[b 7leim 20214026008 1.Microbial Cell Factories 2.International Journal of Biological Macromolecules 3.Synthetic and Systems Biotechnology 4.World Journal of Microbiology and Biotechnology 5. Carbohydrate Polymers+1.SCI 2.SCI 3.SCI4.SCI5.SCI.1.6.4 2.8.2 3.4.80 4.4.1 5.11.2 7&1.N:S 2.N:S 3.N:S 4. N:S 5.N:S61.2023.3. 2.2022.12 3.2023.9. 4.2023.10. 5.2023.10. 7Ng[[1. SCI 2. SCI1. 5.5 2. 16.1 1. N:S 2. N:S 1.2023.09.081.ς]'Yf[of[b 2.ς]'Yf[of[b_lςwxvzuyxN[ReRyv 71.ς]'Yf[ 7jle 1.Journal of Medicinal Chemistry1.N\OrN 1.,{N1.7.3 1.2023.5.29NgsOsO'1.Anal Chem  71.N\OrN  71.,{N  71.7.4  71.N:S  7 1.2023.08.15  7 1.ς]'Yf[of[b  7cz)R 71. BIOCHEMICAL PHARMACOLOGY 71.SCI 2.3uSfN)R 7N\O$N*N,{N  71.5.8 71.N:S 7 1.2023.04.07 7_rsm 1.ANTIOXIDANTS & REDOX SIGNALING1.6.6 1.2023.09.071.ς]'Yf[_l?T1.JOURNAL OF BIOLOGICAL CHEMISTRY 2. JOURNAL OF PROTEOME RESEARCH 3. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms 1.SCI 2.SCI 3.SCI 71.5.5 2.4.4 3.4.7 731.2023.4. 2.2023.7 3.2023.7.  7R܏53uSfN)R 7N\Od^Y  1.Efects ofbranched-chain amino acids onShiraia perylenequinone production inmycelium cultures.200*0.65=130 2.Structure characterization of an exopolysaccharide from a Shiraia-associated bacterium and its strong eliciting activity on the fungal hypocrellin production.200*0.25=50 3.Volatiles of Shiraia fruiting body-associated Pseudomonas putida No.24 stimulate fungal hypocrellin production100*0.1=10 4.Bamboo polysaccharides elicit hypocrellin Abiosynthesis ofabambusicolous fungus Shiraia sp. 100*0.65=65 5. Lipopolysaccharides from a Shiraia fruiting body-associated bacterium elicit host fungal hypocrellin A biosynthesis through nitric oxide generation 200*0.25=50k n     731.NrN 2.NrN 3. NrN 4.NrN 5.N 7#1.N 2.N 3. N 4.N 5.N 7 1.Rationally Designed Nonapeptides with Great Skin Photoprotective Effect through Producing Type 1 Collagen and Blocking the mTOR PathwayN:S rN 200*0.65=130  7 1.Novel Approach to Enriching Glycosylated RNAs: Specific Capture of GlycoRNAs via Solid-Phase Chemistry.(N:S rN IF= 7.4 200* 0.65=130  7! 1.The aryl sulfonamide indisulam inhibits gastric cancer cell migration by promoting the ubiquitination and degradation of the transcription factor ZEB1. (N:S N\O IF=5.5) 200*0.1=20 2. Proximity Proteomics and Biochemical Analysis Reveal a Noncanonical Function for UFM1-Specific Protease 1 in the p62 Body Formation. (N:S N\O IF=4.4) 100*0.1=10 3. The fine-tuned crosstalk between lysine acetylation and the circadian rhythm.(N:S N\O IF=4.7, ~QJS 100*0.65*0.5=32.5 z |  71. NrN 2. NrN 3.NrN  7 1.N:S 2.N:S 3.N:S  1.ς]'Yf[ 2.ς]'Yf[ 3.ς]'Yf[  Ny:@QLpl_c$OGrSvQ(W_Seo-Nv^(u(ct)10  7f[b 7  1.N\O 2.N\O0Rׂ*1. CHEMICAL COMMUNICATIONS 2. ChemBioChem  1.N:S 2. N:S 1.2023.04.102.2022.11.30/ 1.Dichloromethanol but not difluoromethanol as a viable surrogate of carbon monoxide for prodrug designN:S N\O IF=4.9 100*0.45=450 2.Photoclick and Release: Co-activation of Carbon Monoxide and a Fluorescent Self-reporter, COCOS or Sulfonamide with Fast Kinetics N:S N\O IF=3.2 100*0.45=450 g ~ (*  7  1.4.9 2.3.2 71.qQNcN $N*NqQN 2.qQNcN $N*NqQN  7P1. Frontiers in Cell and Developmental Biology 2.advanced drug delivery reviews 7 1. Chlorpromazine affects autophagy in association with altered Rag GTPase mTORC1 TFEB signaling (N:S rN IF=5.5 200* 0.65=130 2. Targeted to neuronal organelles for CNS drug development (N:S d[^YV\O N{RIF=16.1 =0 y |  71. ,{N 2. V\Od[^Y  71. N\OrN 2. V\Od[^Y  71.SCI  7 1.Mechanistic Insights of NAC1 Nuclear Export and Its Role in Ovarian Cancer Resistance to Docetaxel 200*0.45=90 2.N)R OS TXHevuS]LvMQuluoir~TirSvQ(uCN202210676470 ct d^Yc T,{N 10np 7  1.Cystathionine b-Synthase Suppresses NLRP3 Inflammasome Activation via Redox Regulation in MicrogliaN:S qQN IF=6.6 200*1/3=66.7 2. VQSfN)RNADPH(W6RYlu͑'`bu0STbu0RS-NTbub^y~puoirv(ud^Yc,{N ct 10~   71.N\O3*NqQN 2.d^Yc,{N 7 {|+RSCI/SCIE/8h_g R/nfg R) \=r 1.Novel Approa< ch to Enriching Glycosylated RNAs: Specific Capture of GlycoRNAs via Solid-Phase Chemistry.N:S N\O IF=7.4 200*0.25=50 2. Deciphering protein O-GalNAcylation: method development and disease implication. (N:S N\O IF=4.1 100*0.65*0.5=32.5) ~ 3.SfN)RSe^S2023062501369730 50 j    7"1.Analytical chemistry 2.ACS Omega 1.SCI 2.SCI 1.N\O 2.N\O 1.7.4 2.4.1 1.N:S 2.N:S 1.2023.7.31 2.2023.5.24 1.ς]'Yf[of[b 2.ς]'Yf[of[b Ng^^X 1.The Multiple Roles of Autophagy in Neural Function and DiseasN:S N\O IF=5.6 ~RNJSRpe 100U 1.Neuroscience Bulletin N\Od\OY,{N ,{N1.5.6 2023.10.16 _ׂׂ 1.NyF }{|STir(W6RYlupoir-Nv^(u3uSfN)R 10 2.Isolation, structural characterization, and bioactivities of neutral polysaccharides from Zizania latifolia.N:S qQN,{N IF=8.2 66.67 "  7=1.3uSfN)R 2.International Journal of Biological Macromolecules1.3uSfN)R 2.SCI1.d[^Yc T,{N 2.N\O1.d[^Yc T,{N 2.,{N2. 8.22.N:S1.2022.12.15 2.2023.10.25 f^b{ Tumor immunosuppression relief via acidity modulation combined PD-L1 siRNA for enhanced immunotherapy.N:S qQN,{N IF=7.9 66.67v  7Biomaterials AdvancesqQNqQN,{N 2023.4.11 _hT h FDW028, a novel FUT8 inhibitor, impels lysosomal proteolysis of B7-H3 via chaperone-mediated autophagy pathway and exhibits potent efficacy against metastatic colorectal cancerN:S NqQNcN IF =9 66.67  7Cell Death & Disease,{NY/c 1.Ny|{|STir(W~hKmňnSvQO(uel0SfNNg{O Y/c03uS202310514004010 2.lsolation, structural characterization, and bioactivities of neutrapolysaccharides from Zizania latifoliaN:S NNqQN IF=8.2)66.7  7Roe Bioanalysis of Oligonucleotide by LC-MS: Effects of Ion Pairing Regents and Recent Advances in Ion-Pairing-Free Analytical Strategies (N:S N\O IF=5.924) ~ 65  7+International Journal of Molecular SciencesSCIENgR`swa# 1. Antioxidant peptides, the guardian of life from oxidative stress N:S N\O 13.3 ~ 25 2. Rationally Designed Nonapeptides with Great Skin Photoprotective Effect through Producing Type 1 Collagen and Blocking the mTOR Pathway N:S N\O 7.3 20 3. NyNS }-b̃vPTirSvQ^(u 3uSfN)R 10V W Y !  7S1. Medicinal Research Reviews 2.Journal of Medicinal Chemistry 3.3uSfN)Rd[^Yc T,{N 1.SCI 2.SCI 3.3uN)R1.N\O 2. N\O 3.d[^Yc T,{N1. 13.3 2. 7.3 1.N:S 2. N:S1. 2023.8. 25 2. 2023. 5. 291.ς]'Yf[of[b 2.ς]'Yf[of[b 3. ς]'Yf[of[b^t&t Mitochondria associated ER membranes and cerebral ischemia: Molecular mechanisms and therapeutic strategies $NqQN ~ 200*0.5*0,05=50s  7PHARMACOLOGICAL RESEARCHqQN,{N_>eQ 1.One-pot preparation of bi-functional POSS-based hybrid monolith via photo-initiated polymerization for isolation of extracellular vesicles. (N:S N\O IF 6.2) 20 2.Ti3C2 and Ti2C MXene materials for high-performance isolation of extracellular vesicles via coprecipitation (N:S N\O IF 6.2) 20 3.Ny(uN[Ɩ~ހYVlvZIF-8-DSPEPgeSvQ6RYelT^(u(3uSfN)R)10 ! # O  7:1.Analytica Chimica Acta 2.Analytica Chimica Acta 3.3uSfN)R1.SCI 2.SCI 3.3uSfN)R1. N\O2. N\O3.d[^Yc,{N 1. 6.2 2. 6.2 1.N:S 2.N:S1.2023.9.6 2.2023.5.241.ς]'Yf[of[b2.ς]'Yf[of[b闹 Deficient chaperone-mediated autophagy facilitates LPS-induced microglial activation via regulation of the p300/NF-B/NLRP3 pathway.N:S N\O IF=13.6 50  7Science AdvancesN\OsP[i IFN- promotes radioresistant Nestin-expressing progenitor regeneration in the developing cerebellum by augmenting Shh ligand productionN\O N:S IF=5.5 50  7CNS Neuroscience & Therapeutics 2023.10.4vssd Chlorpromazine harms autophagy in association with altered Rag GTPase-mTORC1-TFEB signalingN:S N\O 50b  7+Frontiers in Cell and Developmental Biology 2023.09.08Ğs-Nof[ Cell surface glycoproteomics: deciphering glycoproteins through a unique analytical capture approach N:S$NqQN ~ 100*0.45*0.5=22.5X  7analytical methods N:SSfN)Rd[^Yc T,{N3SU 1.Ny(uWhV[Gr!jWWT N~zSOYhV[Gr3uS 202211528732.9 10 2.NySOm'Yv_hKmel3uS 202310257963.9 10, / S 1.SfN)R3u 2.SfN)R3u 1.ς]'Yf[ 2.ς]'Yf[O݄)Y6qoirSf[  _eP O݄I{ NyΑlYNcSirSvQĞnMO(W6RY2blunu'`~poir-Nv^(u 3uS2023104543330 3ue2023-04-25 10 _eP O݄I{ NyΑlYNcSirSvQĞnMO(W6RY2blunu'`~poir-Nv^(u 3uS2023104543330 3ue2023-04-25 10M P  7wer Rationally Designed Nonapeptides with Great Skin Photoprotective Effect through Producing Type 1 Collagen and Blocking the mTOR Pathway.(N:SN\O IF=7.446) 200*0.25=50  7Journal of Medicinal ChemistrySCI  N\O  N:S 2023.05.29< ς]'Yf[of[b s& Identification of immune activation-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinomaN:S qQN IF=7.3 200*0.25=50 Frontiers in Immunology 7 ,{NqQV*NqQN 2023.7.7 ς]'Yf[,{ND^\;SbYy NyW}vfhxSTir(W6RYvuoir-Nv^(u(SfNRs=N GA4qYLxd$(^bF!Р?H°)RLp!/М;ʅ!PL3 1ŷ_O@HD/?/ox[!MD f JNFb+1 m鞊f>\ƻ'7Y*|3N.Å7543*nC.NR#ٍ#éIBz>]wi(Sk!94_C' ڱ=̧69ty*HqªUr0aד <QoL#@ߊoB})=Ѽ9"A7IhWQw!S}g4rD /o`&*ݩ Mllz9QO K6{bqz[V?_O˯R UZ76-xvx7 Ԍ[tq5s%,Q4rpf \}@U*ܢZ<_d${Gu"Vz`3Vd߀yTe8]7RgO#KRtZ͕fB 1REp *ad6Y>fPM:\X/(ԁLHelCL!Rʿ^jt>)V!1)kdBBUuveDξ楔Ox|Fl*1_*3>LE/pcm']8fYrSd 7Z`*n^ٍrWŤ%R *z?ˈձ@#) sBYLþi*69mY&LiHł=(K& V.KLDUĕ{D ꦚeNƟg(MN5ߜJV6&3(a/E4r;,/ު"zbf58WV="\pkAf!xqQc, !_C:P[| l lt#h &Mwjf})m%.В4vٜ\LcvlmN55xdФ8ǘh/]| /S &z%0YPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!ntheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK]  T8  v  dMbP?_*+%&ffffff?'ffffff?(?)?M:of[bSbpS:gOP-9GS5RP1\of[bSbpS:g,LocalOR\ 4d,,A4R!Multi-model Print Driver 2N@ dH , [SOp_0" d,,333333?333333?&<3U} C} C} C} `C} `/C}  C} C}  C} C} ` C} ` C} @C} C}  C} @C}  C} @C} C 305 W@D_ @ @t@O @ @ X@ D Db D D D E D D% D D D D D D D D D D ~ ? & t  W?  W@  WA  WB  WC WW~ W@`@ X~ Y@ Y YDY|  >@<YZ7ggD T8 ޴:  dMbP?_*+%&ffffff?'ffffff?(?)?M:of[bSbpS:gOP-9GS5RP1\of[bSbpS:g,LocalOR\ 4d,,A4R!Multi-model Print Driver 2N@ dH , [SOp_0" d,,333333?333333?&<3U} L}  L}  L} M}  L}  1N} N}  N} ` N} N} N} N} N}  N}  N}  L}  K}  K 132.5;;;;;; W    W@t" ttWtt F F F G F H F Ft F F F F F F F F F { F~ ? &     ~ @ &    ~ @ & pqrB  ~ @ & qrB  ~ @ &    ~ @ &     ~ @ & qrB  ~ c @ c cudlqrB c cv cw cx cy c  cz  c{  c|  c} cc~ c`@ |~ c"@ c c~ d$rrB c c f c c c c c c c cc~ cY@ | ~ g$@ g g hqrB i g g g g g g g g g gg~ g@ } ~ g&@ g j k{B l l l l l l~ l"@ l~ m @ l jj~ j@ } ~ g(@ g j kzB j j jjjjjjjjjj~ j@ } ~ g*@ g g h rrB g g g g g g~ g@ g g g gg~ g @ } ~ n,@ n opzB q q q q q  q~  q@  q~  r@  q oo~ q@P@ ~~ n.@ n opzB q q q q q o  q  q  q  q oo~ qK@ ~~ n0@ n op({B q q q q q  q q"@  q~  r@  q oo~ qI@ ~~ zv@ ~ n1@ n opzB q q q q q o  q  q  q  q oo~ qI@ ~~ z@~ n2@ n opzB q q q q q o~  q@@  q~  r@  q oo~ qI@ ~~ z@~ n3@ n nsqrB n n n n n  n~  n@  n  n  n nn~ nI@ ~~ zU@~ n4@ t tuqrB t t t t t t~  t@  t  t  t tt~ tI@ ~~ z@~ n5@ v& vvXB v w n v x  y~  nІ@  x  v  v vv~ yI@ ~ zV@~ F6@ J& IITB I J J I J I~  IІ@  J  I  S II~ II@~ z U@2   >@F 7ggD T8  w  dMbP?_*+%&ffffff?'ffffff?(?)?"333333?333333?j&<3U} } } } }  K 10KWKKK? CC@ K\ K F F F G F H F Ft F F F F F F F F F F~ T? T TUTx@  7ggD Pdt  ΢û½͢Microsoft Excel@+b@gN@Bv) ՜.+,D՜.+, PXl t|  ΢й ʿ˶ʿҩ (S[DocumentSummaryInformation8CompObjhwKSOProductBuildVerICV2052-11.1.0.10723$565DB40E76E348EFA2976C75621E9683 FMicrosoft Excel 2003 Biff8Excel.Sheet.89q